CRI Worldwide, which recently acquired Lifetree Clinical Research, has united the two companies under the new brand of CRI Lifetree. The combined company includes CRI’s expertise in psychiatry and in complex studies with Lifetree’s clinical trial management and site expertise in Phase I-III pain management and abuse liability studies. “CRI Lifetree is grounded in sound science,” said Alice Jackson, CRI Lifetree’s president. “We give our clients the innovation they are looking for, from entrepre...